Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies

被引:39
作者
Cardos, Ioana Alexandra [1 ]
Zaha, Dana Carmen [2 ]
Sindhu, Rakesh K. [3 ]
Cavalu, Simona [2 ]
机构
[1] Univ Oradea, Fac Med & Pharm, Doctoral Sch Biomed Sci, 1 Univ St, Oradea 410087, Romania
[2] Univ Oradea, Fac Med & Pharm, Dept Preclin Sci, 1 Univ St, Oradea 410087, Romania
[3] Chitkara Univ, Chitkara Coll Pharm, Chandigarh 140401, India
关键词
Helicobacter pylori; antibiotic resistance; alternative therapy; nanoformulations; RUMEX-AQUATICUS HERBA; GARLIC ALLIUM-SATIVUM; HELICOBACTER-PYLORI; TRIPLE THERAPY; GASTRIC-CANCER; IN-VITRO; CONCOMITANT THERAPY; QUADRUPLE THERAPY; ANTIMICROBIAL RESISTANCE; PRECANCEROUS LESIONS;
D O I
10.3390/molecules26196078
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The prevalence of Helicobacter pylori infection remains significant worldwide and it depends on many factors: gender, age, socio-economic status, geographic area, diet, and lifestyle. All successful infectious diseases treatments use antibiotic-susceptibility testing, but this strategy is not currently practical for H. pylori and the usual cure rates of H. pylori are lower than other bacterial infections. Actually, there is no treatment that ensures complete eradication of this pathogen. In the context of an alarming increase in resistance to antibiotics (especially to clarithromycin and metronidazole), alternative and complementary options and strategies are taken into consideration. As the success of antibacterial therapy depends not only on the susceptibility to given drugs, but also on the specific doses, formulations, use of adjuvants, treatment duration, and reinfection rates, this review discusses the current therapies for H. pylori treatment along with their advantages and limitations. As an alternative option, this work offers an extensively referenced approach on natural medicines against H. pylori, including the significance of nanotechnology in developing new strategies for treatment of H. pylori infection.
引用
收藏
页数:21
相关论文
共 173 条
[11]   Protective effect of Korean Red Ginseng extract against Helicobacter pylori-induced gastric inflammation in Mongolian gerbils [J].
Bae, Minkyung ;
Jang, Sungil ;
Lim, Joo Weon ;
Kang, Jieun ;
Bak, Eun Jung ;
Cha, Jeong-Heon ;
Kim, Hyeyoung .
JOURNAL OF GINSENG RESEARCH, 2014, 38 (01) :8-15
[12]   Effect of propolis in gastric disorders: inhibition studies on the growth of Helicobacter pylori and production of its urease [J].
Baltas, Nimet ;
Karaoglu, Sengul Alpay ;
Tarakci, Cemre ;
Kolayli, Sevgi .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 :46-50
[13]   Pre-formulation of liposomes against Helicobacter pylori:: Characterization and interaction with the bacteria [J].
Bardonnet, Pierre-Louis ;
Faivre, Vincent ;
Boullanger, Paul ;
Piffaretti, Jean-Claude ;
Falson, Francoise .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 69 (03) :908-922
[14]   Identification of Phenolic Compounds from Hancornia speciosa (Apocynaceae) Leaves by UHPLC Orbitrap-HRMS [J].
Bastos, Katherine Xavier ;
Dias, Clarice Noleto ;
Nascimento, Yuri Mangueira ;
da Silva, Marcelo Sobral ;
Zucolotto Langassner, Silvana Maria ;
Wessjohann, Ludger A. ;
Tavares, Josean Fechine .
MOLECULES, 2017, 22 (01)
[15]   Histamine, xanthine oxidase generated oxygen-derived free radicals and Helicobacter pylori in gastroduodenal inflammation and ulceration [J].
Ben-Hamida, A ;
Man, WK ;
McNeil, N ;
Spencer, J .
INFLAMMATION RESEARCH, 1998, 47 (04) :193-199
[16]   Essential oils as components of a diet-based approach to management of Helicobacter infection [J].
Bergonzelli, GE ;
Donnicola, D ;
Porta, N ;
Corthésy-Theulaz, IE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) :3240-3246
[17]  
Berning Marco, 2011, Therap Adv Gastroenterol, V4, P103, DOI 10.1177/1756283X10384171
[18]   Antibacterial activities of almond skins on cagA-positive and-negative clinical isolates of Helicobacter pylori [J].
Bisignano, Carlo ;
Filocamo, Angela ;
La Camera, Erminia ;
Zummo, Sebastiana ;
Fera, Maria Teresa ;
Mandalari, Giuseppina .
BMC MICROBIOLOGY, 2013, 13
[19]   Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment -: Preliminary experience [J].
Bock, H ;
Koop, H ;
Lehn, N ;
Heep, M .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2000, 31 (03) :222-225
[20]  
Borsch GM, 1991, Handbook of Experimental Pharmacology, V99, P107